
Joseph R. Kosack
Examiner (ID: 2168)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 3991, 1626 |
| Total Applications | 1842 |
| Issued Applications | 1291 |
| Pending Applications | 100 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19067107
[patent_doc_number] => 20240101533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/205877
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18205877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/205877 | Methods and intermediates for preparing therapeutic compounds | Jun 4, 2023 | Issued |
Array
(
[id] => 18955098
[patent_doc_number] => 20240043425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/319585
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319585
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319585 | Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof | May 17, 2023 | Issued |
Array
(
[id] => 19111160
[patent_doc_number] => 20240122910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/319287
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319287
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319287 | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | May 16, 2023 | Issued |
Array
(
[id] => 18771242
[patent_doc_number] => 20230366059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHOD FOR SEPARATION OF ADJACENT LANTHANIDE ELEMENTS
[patent_app_type] => utility
[patent_app_number] => 18/195099
[patent_app_country] => US
[patent_app_date] => 2023-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195099
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/195099 | METHOD FOR SEPARATION OF ADJACENT LANTHANIDE ELEMENTS | May 8, 2023 | Pending |
Array
(
[id] => 18807407
[patent_doc_number] => 20230381740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => MULTIVARIATE METAL-ORGANIC FRAMEWORKS FOR FINE-TUNING LIGHT EMISSION
[patent_app_type] => utility
[patent_app_number] => 18/143781
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18143781
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/143781 | Multivariate metal-organic frameworks for fine-tuning light emission | May 4, 2023 | Issued |
Array
(
[id] => 19372876
[patent_doc_number] => 12064415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Psilocin prodrug compounds and methods of synthesizing the same
[patent_app_type] => utility
[patent_app_number] => 18/142263
[patent_app_country] => US
[patent_app_date] => 2023-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15001
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18142263
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/142263 | Psilocin prodrug compounds and methods of synthesizing the same | May 1, 2023 | Issued |
Array
(
[id] => 19948605
[patent_doc_number] => 12319954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Morphinan compounds
[patent_app_type] => utility
[patent_app_number] => 18/306710
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10845
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18306710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/306710 | Morphinan compounds | Apr 24, 2023 | Issued |
Array
(
[id] => 18748341
[patent_doc_number] => 11807637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-07
[patent_title] => Compound and use thereof in treating autoimmune diseases
[patent_app_type] => utility
[patent_app_number] => 18/138817
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 12588
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138817
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138817 | Compound and use thereof in treating autoimmune diseases | Apr 24, 2023 | Issued |
Array
(
[id] => 18557082
[patent_doc_number] => 20230255101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Tetradentate Metal Complexes with Carbon Group Bridging Ligands
[patent_app_type] => utility
[patent_app_number] => 18/302995
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18302995
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/302995 | Tetradentate metal complexes with carbon group bridging ligands | Apr 18, 2023 | Issued |
Array
(
[id] => 18597169
[patent_doc_number] => 20230271961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Pan-Tropic Entry Inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/132777
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132777 | Pan-tropic entry inhibitors | Apr 9, 2023 | Issued |
Array
(
[id] => 19896800
[patent_doc_number] => 12274694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Dizocilpine derivatives as peripheral NMDA receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 18/296543
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 14574
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296543
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296543 | Dizocilpine derivatives as peripheral NMDA receptor antagonists | Apr 5, 2023 | Issued |
Array
(
[id] => 18565649
[patent_doc_number] => 20230255976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates
[patent_app_type] => utility
[patent_app_number] => 18/295667
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295667 | Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates | Apr 3, 2023 | Pending |
Array
(
[id] => 19563509
[patent_doc_number] => 12138259
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-11-12
[patent_title] => Method of controlling depression in subjects treated for opioid dependence
[patent_app_type] => utility
[patent_app_number] => 18/194678
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11235
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/194678 | Method of controlling depression in subjects treated for opioid dependence | Apr 2, 2023 | Issued |
Array
(
[id] => 19990889
[patent_doc_number] => 20250129111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => RUTHENIUM PRECURSOR COMPOSITION, PREPARATION METHOD THEREFOR, AND FORMATION METHOD FOR RUTHENIUM-CONTAINING FILM USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/854563
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18854563
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/854563 | Ruthenium precursor composition, preparation method therefor, and formation method for ruthenium-containing film using same | Mar 29, 2023 | Issued |
Array
(
[id] => 19778467
[patent_doc_number] => 12227491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => EGFR inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/187430
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15238
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187430
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187430 | EGFR inhibitors | Mar 20, 2023 | Issued |
Array
(
[id] => 18589211
[patent_doc_number] => 11738083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-29
[patent_title] => BODIPY-based rhombic metal ring, preparation method thereof, and application in near-infrared region imaging
[patent_app_type] => utility
[patent_app_number] => 18/182287
[patent_app_country] => US
[patent_app_date] => 2023-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 2956
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182287
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182287 | BODIPY-based rhombic metal ring, preparation method thereof, and application in near-infrared region imaging | Mar 9, 2023 | Issued |
Array
(
[id] => 18628144
[patent_doc_number] => 20230286981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 18/171735
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171735
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/171735 | Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer | Feb 20, 2023 | Pending |
Array
(
[id] => 18466920
[patent_doc_number] => 20230201200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Methods for Treating Huntington's Disease
[patent_app_type] => utility
[patent_app_number] => 18/111421
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111421 | Methods for Treating Huntington's Disease | Feb 16, 2023 | Abandoned |
Array
(
[id] => 18861810
[patent_doc_number] => 20230416245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/169321
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169321
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169321 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | Feb 14, 2023 | Pending |
Array
(
[id] => 18511314
[patent_doc_number] => 20230227452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => NONMUSCLE MYOSIN II INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/169660
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169660 | Nonmuscle myosin ii inhibitors | Feb 14, 2023 | Issued |